TY - JOUR
T1 - Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia
AU - Bachetti, Tiziana
AU - Pasini, Evasio
AU - Suzuki, Hisanori
AU - Ferrari, Roberto
PY - 2003/5/1
Y1 - 2003/5/1
N2 - Objective: The derangement of the nitric oxide pathway is an important contributing factor to the pathogenesis of septic shock. The aim of this study was to investigate potential differences in modulation of such a pathway in two experimental models of endotoxemia. Design: Prospective, randomized, placebo-controlled animal investigation. Setting: Cardiovascular research laboratory. Subjects: Male, anesthetized, and mechanically ventilated New-Zealand rabbits (n = 24) and Sprague-Dawley rats (n = 24). Interventions: After pretreatment with 1400W (1 mg kg-1 subcutaneously), an inhibitor of inducible nitric oxide synthase, animals received an intravenous bolus of Escherichia Coli lipopolysaccharides (5 mg kg-1). After 4 hrs, lungs, myocardial left ventricles, and aortas were collected. Measurements and Main Results: Blood mean arterial pressure, pH, and nitrite/nitrate were monitored. Nitric oxide in the exhaled air was measured by chemiluminescence. Tissue activity of both constitutive nitric oxide synthase and inducible nitric oxide synthase was determined by measuring the conversion of [3H]L-arginine to [3H]L-citrulline. In lipopolysaccharide-treated animals, both mean arterial pressure (after 60 to 90 mins) and blood pH (after 4 hrs) decreased with respect to baseline values. 1400W prevented lipopolysaccharide-induced hypotension only in rats (p <.01). Exhaled nitric oxide decreased in lipopolysaccharide-treated rabbits by 120 mins (from 12.6 ± 0.6 to 8.4 ± 0.6 ppb, p <.01) and remained low until the end of the experiment (p <.01 vs. baseline). Conversely, exhaled nitric oxide increased in lipopolysaccharide-treated rats by 120 mins (from 0.4 ± 0.1 to 5.3 ± 1.7 ppb, p <.01) and reached a plateau by 210 mins (19.8 ± 3.1 ppb, p <.01 vs. baseline). 1400W prevented the lipopolysaccharide-induced increase in exhaled nitric oxide and blood nitrite/nitrate in rats (p <.05). Inducible nitric oxide synthase activity increased in endotoxemic rabbit heart (0.19 ± 0.05 vs. 0.07 ± 0.02 pmol L-citrulline/min/mg protein in the control group, p <.05) and in all rat tissues, being more striking in the lungs (25.00 ± 0.01 vs. 0.19 ± 0.04 pmol L-citrulline/min/mg protein in the control group, p <.001). Conclusions: The nitric oxide pathway is differently modulated between endotoxemic rabbits and rats.
AB - Objective: The derangement of the nitric oxide pathway is an important contributing factor to the pathogenesis of septic shock. The aim of this study was to investigate potential differences in modulation of such a pathway in two experimental models of endotoxemia. Design: Prospective, randomized, placebo-controlled animal investigation. Setting: Cardiovascular research laboratory. Subjects: Male, anesthetized, and mechanically ventilated New-Zealand rabbits (n = 24) and Sprague-Dawley rats (n = 24). Interventions: After pretreatment with 1400W (1 mg kg-1 subcutaneously), an inhibitor of inducible nitric oxide synthase, animals received an intravenous bolus of Escherichia Coli lipopolysaccharides (5 mg kg-1). After 4 hrs, lungs, myocardial left ventricles, and aortas were collected. Measurements and Main Results: Blood mean arterial pressure, pH, and nitrite/nitrate were monitored. Nitric oxide in the exhaled air was measured by chemiluminescence. Tissue activity of both constitutive nitric oxide synthase and inducible nitric oxide synthase was determined by measuring the conversion of [3H]L-arginine to [3H]L-citrulline. In lipopolysaccharide-treated animals, both mean arterial pressure (after 60 to 90 mins) and blood pH (after 4 hrs) decreased with respect to baseline values. 1400W prevented lipopolysaccharide-induced hypotension only in rats (p <.01). Exhaled nitric oxide decreased in lipopolysaccharide-treated rabbits by 120 mins (from 12.6 ± 0.6 to 8.4 ± 0.6 ppb, p <.01) and remained low until the end of the experiment (p <.01 vs. baseline). Conversely, exhaled nitric oxide increased in lipopolysaccharide-treated rats by 120 mins (from 0.4 ± 0.1 to 5.3 ± 1.7 ppb, p <.01) and reached a plateau by 210 mins (19.8 ± 3.1 ppb, p <.01 vs. baseline). 1400W prevented the lipopolysaccharide-induced increase in exhaled nitric oxide and blood nitrite/nitrate in rats (p <.05). Inducible nitric oxide synthase activity increased in endotoxemic rabbit heart (0.19 ± 0.05 vs. 0.07 ± 0.02 pmol L-citrulline/min/mg protein in the control group, p <.05) and in all rat tissues, being more striking in the lungs (25.00 ± 0.01 vs. 0.19 ± 0.04 pmol L-citrulline/min/mg protein in the control group, p <.001). Conclusions: The nitric oxide pathway is differently modulated between endotoxemic rabbits and rats.
KW - Animal
KW - Endotoxemia
KW - Exhaled nitric oxide
KW - Lipopolysaccharide
KW - Nitric oxide synthase
UR - http://www.scopus.com/inward/record.url?scp=0037905000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037905000&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000063269.35714.7E
DO - 10.1097/01.CCM.0000063269.35714.7E
M3 - Article
C2 - 12771626
AN - SCOPUS:0037905000
VL - 31
SP - 1509
EP - 1514
JO - Critical Care Medicine
JF - Critical Care Medicine
SN - 0090-3493
IS - 5
ER -